Zydus Cadila gets USFDA nod for muscle relaxant injection
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Drug firm Zydus Cadila has received final approval from the US health regulator to market Cisatracurium Besylate Injection, a muscle relaxant given before general anaesthesia.

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Cisatracurium Besylate Injection USP in the strength of 20 mg (base)/10 mL (2 mg/mL) multiple-dose vial, Cadila Healthcare said in a regulatory filing on 2 August.

The drug will be manufactured at Liva plant of Cadila Healthcare Ltd.

Source: https://www.deccanherald.com/science-and-environment/zydus-cadila-gets-usfda-nod-for-muscle-relaxant-injection-881439.html
Dr. T●●●●z H●●●●●●i and 4 others like this
Like
Comment
Share